Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499
NCT01328821
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Nephropathy
Interventions
DRUG:
CTP-499
DRUG:
CTP-499
Sponsor
Concert Pharmaceuticals